- Home
- Guides
- Diabetes medicines in the Jan Aushadhi list: salts, NPPA ceilings and how to compute savings
Source-backedPrescription medicines: ask your doctor
Diabetes medicines in the Jan Aushadhi list: salts, NPPA ceilings and how to compute savings
Many diabetes salts appear in the Jan Aushadhi (PMBJP) list, including metformin, glimepiride, gliclazide, sitagliptin and several insulins. The list gives strengths and packs but not prices. This guide shows NPPA ceiling prices where scheduled and a method to compare costs. Ask your doctor before changing any medicine.
- Salts found in PMBJP list
- Metformin, glimepiride, gliclazide, glipizide, pioglitazone, gliptins, voglibose, acarbose, insulins and more
- PMBJP prices in the static list
- Not given; ask the Kendra
- NPPA ceiling examples
- Metformin 500 mg Rs 2.07; glimepiride 2 mg Rs 5.94 per tablet (March 2026)
- On NLEM 2022
- Metformin, glimepiride, teneligliptin, insulins
- List date
- PMBJP list till 31.12.2025
What this guide covers
The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) publishes a list of generic medicines sold through Jan Aushadhi Kendras. This guide checks which diabetes-related salts appear in that list.
We found 42 single-salt entries and 96 combination entries for diabetes medicines in the 2110-item list. We also show the government price ceiling per unit where one exists.
The static PMBJP list gives product names, strengths and packs only. It does not give prices, so we show none.
The list shows what a Kendra may stock. It does not show prices; ask the Kendra for the current price.
Source1
Diabetes salts in the PMBJP list, with price ceilings
The table lists single-salt entries only. Combination products are described in the next section. Ceiling prices come from NPPA lists as on March 2026 for scheduled formulations.
A salt with no ceiling shown is not in the scheduled lists we checked. That does not mean there is no price rule; it means we did not find it.
| Salt | Strengths and packs listed in PMBJP | NPPA ceiling per unit (where scheduled) | On NLEM 2022 |
|---|---|---|---|
| Metformin | 1000 mg (10's); 500mg (10's); 500 mg (10's); 850mg (10's); 250 mg (10's) | Tablet 500 mg Rs 2.07, 1000 mg Rs 3.57; modified release 1000 mg Rs 4.15 (per tablet, March 2026) | Yes (500 mg, 1000 mg, modified release 1000 mg) |
| Glimepiride | 1mg (10's); 2mg (10's); 3mg (10's); 4mg (10's); 0.5mg (10's) | 1 mg Rs 3.78, 2 mg Rs 5.94 per tablet (March 2026) | Yes (1 mg, 2 mg) |
| Gliclazide | 40 mg (10's); 80 mg (10's); 60 mg (10's) | Not found in the scheduled lists we checked | Not found in the lists we checked |
| Glibenclamide | 2.5 mg (10's); 5 mg (10's) | Not found in the scheduled lists we checked | Not found in the lists we checked |
| Glipizide | 5 mg (10's) | Not found in the scheduled lists we checked | Not found in the lists we checked |
| Pioglitazone | 30mg (10's); 15 mg (10's) | Not found in the scheduled lists we checked | Not found in the lists we checked |
| Vildagliptin | 50mg (15's) | Not found in the scheduled lists we checked | Not found in the lists we checked |
| Sitagliptin | 100mg (10's); 50mg (10's) | Not found in the scheduled lists we checked | Not found in the lists we checked |
| Teneligliptin | 20mg (10's) | 20 mg Rs 11.35 per tablet (March 2026) | Yes (20 mg) |
| Linagliptin | 5mg (10's) | Not found in the scheduled lists we checked | Not found in the lists we checked |
| Voglibose | 0.3 mg (10's); 0.2 mg (10's) | Not found in the scheduled lists we checked | Not found in the lists we checked |
| Acarbose | 50 mg (10's); 25 mg (10's) | Not found in the scheduled lists we checked | Not found in the lists we checked |
| Repaglinide | 0.5mg (10's); 1mg (10's); 2mg (10's) | Not found in the scheduled lists we checked | Not found in the lists we checked |
| Dapagliflozin | 10 mg (10's); 5mg (10's) | Not found in the scheduled lists we checked | Not found in the lists we checked |
| Empagliflozin | 10 mg (10's); 25 mg (10's) | Not found in the scheduled lists we checked | Not found in the lists we checked |
| Insulin | 40 IU per ml (10 ml Vial); 40 IU per ml (10 ML VIAL); 100 IU per ml (Cartridge 3 ml); 100 IU per ml (3 ml Catridge); 100IU per ml (3ml Pre-Filled Cartridge); 100IU per ml (10ml Vial) | Soluble, NPH and 30:70 premix 40 IU/mL: Rs 17.40 per mL; glargine 100 IU/mL: Rs 208.34 per mL (March 2026) | Yes (soluble 40 IU/mL; glargine 100 IU/mL) |
| Evogliptin | 5mg (10's) | Not found in the scheduled lists we checked | Not found in the lists we checked |
| Remogliflozin | 100mg (10's) | Not found in the scheduled lists we checked | Not found in the lists we checked |
Strengths and packs are from the PMBJP list; ceilings are from NPPA.
Combination products in the list
The PMBJP list also carries 96 combination entries. Most pair metformin with a sulfonylurea, a gliptin, a gliflozin, voglibose or pioglitazone, and some combine three salts.
A combination is a different product from its single parts. Ceilings above apply to single salts only, so do not read them across to combinations.
Separately, CDSCO's prohibited list in our database contains 28 rows that mention metformin, glimepiride or pioglitazone in a combination. Check any combination in the banned medicine checker.
Combinations are separate products; single-salt ceilings do not apply to them.
How to compute your own savings
Savings depend on the price you pay now and the price at the Kendra. Work it out in three steps, using the pack you actually buy.
Step 1: note the price on your current pack and divide by the number of tablets to get the price per tablet.
Step 2: ask the Kendra for the price of the same salt, strength and pack, and divide the same way.
Step 3: subtract the two per-tablet prices and multiply by the tablets used in a month.
Worked example with made-up numbers only: if your pack costs Rs 60 for 10 tablets (Rs 6 each) and the Kendra pack costs Rs 15 for 10 (Rs 1.50 each), the gap is Rs 4.50 per tablet. For 60 tablets a month that is Rs 270.
These numbers are hypothetical and are not PMBJP prices. Compare also with the NPPA ceiling in the table, which is the upper limit for a scheduled brand.
Divide pack price by tablets, compare per-tablet prices, multiply by monthly use.
Price and legal status
NPPA fixes ceiling prices for scheduled formulations under the drug price control order. NLEM 2022 lists essential medicines on which those ceilings are based.
Metformin, glimepiride, teneligliptin and insulins are on NLEM 2022 in the strengths shown above. Insulin and most diabetes tablets are sold on prescription.
Jan Aushadhi products are generic equivalents sold under a government scheme. The list we used runs to 31 December 2025 and Kendra stock can differ.
Ceilings are government maxima for scheduled brands; the Kendra sets its own scheme price.
About the questions below
The answers use only the PMBJP list, NPPA ceiling lists and NLEM 2022 in our database. They describe lists, not your treatment.
Frequently asked questions
Is insulin available at Jan Aushadhi Kendras?
The PMBJP list we checked includes several insulin entries, such as soluble, isophane mix and glargine, in vial or cartridge packs. Stock at a given Kendra can differ, so ask the Kendra directly.
Source11
Does the PMBJP list show prices?
The static list we used shows product name, strength and pack, not prices. Ask the Kendra for the current price and compare per tablet.
Source9
What is the NPPA ceiling for metformin 500 mg?
The March 2026 NPPA list shows Rs 2.07 per tablet for metformin 500 mg tablets. That is a ceiling for scheduled brands, not a Kendra price.
Source12
Can I switch to a Jan Aushadhi diabetes medicine?
Ask your doctor or pharmacist first. They can confirm that the salt, strength and release type match your prescription.
Source9
Sources
- 1PMBJP list of 2110 generic medicines (till 31.12.2025) (annexure rows p2:sno32, p6:sno118, p6:sno119, p6:sno120, p6…) Open source · 2026-10-15
- 2PMBJP list of 2110 generic medicines (till 31.12.2025) (single-salt rows, p6:sno118, p6:sno119, p6:sno120, p6:sno12…) Open source · 2026-10-15
- 3NPPA ceiling prices of scheduled formulations (Anti-diabetes, pages 2-3 (as on March 2026)) Open source · 2026-10-15
- 4National List of Essential Medicines 2022 (Section 18.3.1, pages 96-97) Open source · 2026-10-15
- 5PMBJP list of 2110 generic medicines (till 31.12.2025) (combination rows, p2:sno32, p6:sno126, p6:sno130, p12:sno27…) Open source · 2026-10-15
- 6CDSCO list of prohibited drugs and fixed dose combinations (cdsco_banned/updated_banned_drugs_list.pdf, rows mentioning…) Open source · 2026-10-15
- 7PMBJP list of 2110 generic medicines (till 31.12.2025) (price not in static list; method only) Open source · 2026-10-15
- 8NPPA ceiling prices of scheduled formulations (Anti-diabetes, pages 2-3) Open source · 2026-10-15
- 9PMBJP list of 2110 generic medicines (till 31.12.2025) (list till 31.12.2025) Open source · 2026-10-15
- 10NPPA ceiling prices of scheduled formulations (Anti-diabetes lists) Open source · 2026-10-15
- 11PMBJP list of 2110 generic medicines (till 31.12.2025) (p6:sno125, p12:sno277, p27:sno610) Open source · 2026-10-15
- 12NPPA ceiling prices of scheduled formulations (Anti-diabetes, page 3 (as on March 2026)) Open source · 2026-10-15
Last checked: 2026-10-15 · How we use sources · Report a correction
This information is educational and is not a substitute for advice from your doctor or pharmacist. It does not tell you what dose you personally should take. In an emergency call 112.